Skip to content

Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies

Àlvar Farré-colomés, Olga Rublinetska, Oscar Soto-Angona

Discover Mental Health March 19, 2026 DOI: 10.1007/s44192-026-00384-w (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Sample size 20
Population Depression and healthy controls
Topics Default mode network Psilocybin
Keywords Anterior cingulate cortex Dorsolateral prefrontal cortex Functional imaging Functional brain imaging Neuroimaging Dropout neural networks Human studies Data extraction Human brain Magnetic resonance imaging
Key findings The current literature on psilocybin and fMRI exhibits inconsistency in methods and designs, with most research focusing on the amygdala, anterior cingulate cortex, and prefrontal cortex.

Abstract

Psilocybin-assisted therapies are innovative therapeutic approaches, particularly in the treatment of depression. However, there are sparse studies providing functional magnetic resonance imaging (fMRI) evidence elucidating the underlying biological mechanisms that support clinical outcomes. This review aims to comprehensively gather all the evidence reported in psilocybin studies using fMRI techniques. Independent extraction of articles was conducted by 2 authors using predefined data fields. 20 unique datasets were identified, with 5 including participants diagnosed with depression. Dropout rates were found to be high, and follow-up scanning timepoints were lacking in most of the studies. Most research has focused on the amygdala, the anterior cingulate cortex and the prefrontal cortex, as key regions involved in the effects of psilocybin. However, the current literature exhibits inconsistency in methods and designs. Further research is necessary to better define psilocybin’s impact on the human brain and its potential to enhance psychotherapy outcomes.

Comparable studies

Other systematic reviews and meta-analyses on psilocybin, most cited first.

Study Year Design Participants
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188
Blinding and expectancy confounds in psychedelic randomized controlled trials 2021 Systematic review
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis People with elevated symptoms of anxiety and depression 2020 Meta-analysis n = 117
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review

Citations in the library

Explore topics